Gevo raises $107 million in its IPO as synbio stays in the spotlight
February 10, 2011 | Analyst Insight
Earlier this week, isobutanol producer Gevo raised $107 million in its initial public offering (IPO). The synthetic biology company sold approximately 7.1 million shares at $15 apiece, with shares trading as...
About Lux Research
Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.